A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Clinical trial NCT03142451 · COMPLETED

Trial details

NCT number: NCT03142451
Sponsor: Vyne Therapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Facial Papulopustular Rosacea

Start date: 2017-06-02
Primary completion: 2018-08-31
Enrollment: 751

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.